Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
65.38
1.83 (2.88%)
At close: Aug 15, 2025, 3:59 PM
66.25
1.33%
After-hours: Aug 15, 2025, 06:59 PM EDT
Cidara Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -114.49M | -178.18M | -165.03M | -118.33M | -113.52M | -36.47M | -23.13M | -30.89M | -7.74M | -8.51M | -29.8M | -33.23M | -66.29M | -42.46M | -42.47M | -47.3M | -46.85M | -75.86M |
Depreciation & Amortization | 196K | 226K | 233K | 213K | 174K | -146K | -170K | 106K | 394K | 960K | 1.23M | -511K | -704K | -973K | -1.23M | 236K | 183K | 210K |
Stock-Based Compensation | 7.11M | 4.85M | 3.91M | 3.08M | 3.12M | 3.22M | 3.06M | 2.9M | 2.95M | 2.83M | 3.53M | 4.22M | 4.28M | 4.47M | 4.01M | 3.5M | 3.6M | 3.72M |
Other Working Capital | -14.98M | -35.92M | -33.3M | -45.84M | -18.94M | 116K | 2.22M | -4.37M | 4.65M | 4.73M | -584K | 6.22M | 1.75M | 362K | 8.1M | 17.81M | 15.44M | 23.29M |
Other Non-Cash Items | -11.1M | -1.51M | -1.71M | 670K | 3.64M | 3.41M | 3.93M | -536K | 966K | 1.26M | 524K | 2.3M | 529K | 12K | 15K | 16K | 21K | 24K |
Deferred Income Tax | n/a | -5.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -523K | -523K | -523K | -523K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -10.73M | -11.72M | -13.93M | -45.47M | -18.2M | 11.81M | -6.12M | -2.29M | 2.33M | -11.79M | -3.43M | 5.36M | 381K | -8.1M | 14.44M | 22.09M | 19.48M | 30.83M |
Operating Cash Flow | -129.02M | -191.84M | -176.53M | -159.84M | -124.78M | -18.18M | -22.43M | -30.71M | -1.1M | -15.76M | -28.47M | -22.38M | -62.32M | -47.05M | -25.23M | -21.45M | -23.56M | -41.08M |
Capital Expenditures | -106K | -106K | -129K | -307K | -327K | -434K | -505K | -336K | -219K | -128K | -118K | -109K | -112K | -113K | -41K | -41K | -83K | -162K |
Cash Acquisitions | 185K | 185K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 79K | 79K | -129K | -307K | -327K | -434K | -505K | -336K | -219K | -128K | -118K | -109K | -112K | -113K | -41K | -41K | -83K | -162K |
Debt Repayment | -201K | -276K | -276K | -200K | -125K | -50K | n/a | n/a | -371K | -1.48M | -2.59M | -3.7M | -4.44M | -4.44M | -4.44M | -4.44M | -4.44M | -3.33M |
Common Stock Repurchased | 39K | 39K | 39K | n/a | 63K | 63K | 63K | 63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 183K | 50K | 11K | -28K | -28K | -32K | 21K | 14K | -706K | -706K | -720K | -720K | n/a | 5K | 6K | 6K | 15K | -731K |
Financial Cash Flow | 481.49M | 337.23M | 337.06M | 238.86M | 239.05M | -346K | 25.98M | 26.64M | 26.75M | 25.9M | -951K | 35.26M | 34.34M | 36.34M | 44.6M | 8.13M | 12.66M | 15.71M |
Net Cash Flow | 352.54M | 145.47M | 160.4M | 78.72M | 113.94M | -18.96M | 3.05M | -4.41M | 25.42M | 10.01M | -29.54M | 12.77M | -28.09M | -10.82M | 19.32M | -13.36M | -10.99M | -25.52M |
Free Cash Flow | -129.13M | -191.94M | -176.66M | -160.15M | -125.11M | -18.61M | -22.94M | -31.05M | -1.32M | -15.89M | -28.59M | -22.49M | -62.44M | -47.16M | -25.27M | -21.49M | -23.65M | -41.24M |